Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Revenue (2016 - 2025)

Historic Revenue for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $131.9 million.

  • Veracyte's Revenue rose 1382.01% to $131.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $495.1 million, marking a year-over-year increase of 1641.31%. This contributed to the annual value of $445.8 million for FY2024, which is 2346.29% up from last year.
  • Per Veracyte's latest filing, its Revenue stood at $131.9 million for Q3 2025, which was up 1382.01% from $130.2 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Revenue ranged from a high of $131.9 million in Q3 2025 and a low of $36.7 million during Q1 2021
  • In the last 5 years, Veracyte's Revenue had a median value of $90.1 million in 2023 and averaged $89.4 million.
  • Per our database at Business Quant, Veracyte's Revenue surged by 16615.63% in 2021 and then skyrocketed by 1375.19% in 2025.
  • Veracyte's Revenue (Quarter) stood at $67.3 million in 2021, then grew by 19.25% to $80.3 million in 2022, then rose by 22.29% to $98.2 million in 2023, then grew by 20.81% to $118.6 million in 2024, then rose by 11.16% to $131.9 million in 2025.
  • Its Revenue stands at $131.9 million for Q3 2025, versus $130.2 million for Q2 2025 and $114.5 million for Q1 2025.